Capital International Investors

Position in LLY — ELI LILLY & Co

CIK 1562230 Los Angeles, CA

Back to LLY Full portfolio

Position in LLY

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$5,625,949,800

-$4,980,476,485 QoQ

Shares Held

6,116,692

-38.0% QoQ

Ownership

0.650%

of shares outstanding

% of Portfolio

1.41%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.45671614657073.ToString("F0")% Shared 0.ToString("F0")% None 0.5432838534292719.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Capital International Investors holds $19,740,296,250 across 8 Drug Manufacturers - General names. LLY ranks #2 (28.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	34,393,013	$6,782,990,023
2	LLY	ELI LILLY & Co This page	6,116,692	$5,625,949,800
3	ABBV	AbbVie Inc.	14,418,993	$3,135,986,787
4	AMGN	Amgen Inc	7,122,275	$2,505,972,458
5	JNJ	Johnson & Johnson	2,617,363	$639,788,211
6	BMY	Bristol Myers Squibb Co	8,432,445	$511,427,789
7	NVO	Novo Nordisk A S	11,795,850	$433,497,487
8	MRK	Merck & Co., Inc.	870,261	$104,683,695

All Filings in LLY

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,625,949,800	6,116,692	-38.0%	Shares	Defined	2026-05-13
2025-12-31	$10,606,426,285	9,869,380	-1.3%	Shares	Defined	2026-02-11
2025-09-30	$7,631,151,367	10,001,509	+6.1%	Shares	Defined	2025-11-13
2025-06-30	$7,344,831,439	9,422,128	-0.8%	Shares	Defined	2025-08-13
2025-03-31	$7,845,789,032	9,499,569	+8.8%	Shares	Defined	2025-05-12
2024-12-31	$6,740,145,176	8,730,758	+23.2%	Shares	Defined	2025-02-13
2024-09-30	$6,277,359,763	7,085,536	-3.0%	Shares	Defined	2024-11-13
2024-06-30	$6,613,682,295	7,304,869	+4.8%	Shares	Defined	2024-08-13
2024-03-31	$5,424,242,858	6,972,393	+5.1%	Shares	Defined	2024-05-14
2023-12-31	$3,868,742,692	6,636,833	+8.1%	Shares	Defined	2024-02-13
2023-09-30	$3,297,846,066	6,139,754	-1.0%	Shares	Defined	2023-11-13
2023-06-30	$2,907,100,092	6,198,772	-5.2%	Shares	Defined	2023-08-11
2023-03-31	$2,245,249,395	6,537,911	+13.3%	Shares	Defined	2023-05-15
2022-12-31	$2,110,316,943	5,768,415	+3.0%	Shares	Defined	2023-02-14
2022-09-30	$1,810,492,912	5,599,174	+12.8%	Shares	Defined	2022-11-14
2022-06-30	$1,608,824,396	4,961,985	-43.9%	Shares	Defined	2022-08-15
2022-03-31	$2,531,293,445	8,839,241	+30.5%	Shares	Defined	2022-05-19
2021-12-31	$1,871,579,434	6,775,684	-4.9%	Shares	Defined	2022-02-14
2021-09-30	$1,646,518,907	7,126,245	-16.3%	Shares	Defined	2021-11-15
2021-06-30	$1,954,839,972	8,517,079	-4.2%	Shares	Defined	2021-08-16
2021-03-31	$1,661,083,875	8,891,360	-21.8%	Shares	Defined	2021-05-14
2020-12-31	$1,919,393,549	11,368,121	-29.6%	Shares	Defined	2021-02-12
2020-09-30	$2,388,553,001	16,136,691	-23.8%	Shares	Defined	2020-11-13
2020-06-30	$3,477,546,983	21,181,307	-7.0%	Shares	Defined	2020-08-14
2020-03-31	$3,159,597,002	22,776,795	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.